Wall Street Journal. Europe 1999 Michael Waldholz - Abstracts
| Wall Street Journal. Europe 1999 Michael Waldholz | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| AIDS vaccine tests set for Africa, Asia (Rhone-Poulenc, VaxGen plan separate trials).(Abstract) | Business, international | Michael Waldholz, Ralph T. Jr. King | |||
| Glaxo to announce discovery of genes behind three diseases; breakthroughs in migraine, psoriasis, diabetes meant to shake up industry; Dr. Roses points the way.(Glaxo Wellcome PLC and Dr. Allen Roses) | Business, international | Michael Waldholz, Elyse Tanouye | |||
| Pharmacia says drug gets U.S. approval.(Abstract) | Business, international | Michael Waldholz | |||
| Potent brew: blending of AHP and Warner-Lambert signals deals ahead; European drug companies are seen following path of $70 billion transaction; stocking empty cupboards.(American Home Products, includes related article)(Statistical Data Included) | Business, international | Gardiner Harris, Nikhil Deogun, Steven Lipin, Robert Langreth, Michael Waldholz, Elyse Tanouye | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.